Advanced company searchLink opens in new window

SCARLET THERAPEUTICS LIMITED

Company number 13536278

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
22 Aug 2022 MA Memorandum and Articles of Association
17 Aug 2022 AP01 Appointment of Dr Harry Stephen Destecroix as a director on 12 August 2022
17 Aug 2022 SH01 Statement of capital following an allotment of shares on 12 August 2022
  • GBP 158.1896
02 Aug 2022 CS01 Confirmation statement made on 27 July 2022 with updates
01 Aug 2022 PSC04 Change of details for Professor Ashley Mark Toye as a person with significant control on 15 July 2022
20 Jul 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Subdivided shares 15/07/2022
20 Jul 2022 SH02 Sub-division of shares on 15 July 2022
15 Jul 2022 SH01 Statement of capital following an allotment of shares on 15 July 2022
  • GBP 100
14 Jul 2022 AD01 Registered office address changed from 1 Cathedral Square Bristol BS1 5DD England to C/O Veale Wasbrough Vizards Llp Narrow Quay House Narrow Quay Bristol BS1 4QA on 14 July 2022
28 Jul 2021 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2021-07-28
  • GBP 1